Visit the Illumina booth to explore flexible, scalable oncology workflows spanning targeted panels, comprehensive genomic profiling, whole-exome sequencing, whole-genome sequencing, automation, informatics, and reporting.
Discover workflow options for different laboratory throughput needs and learn about emerging innovations in molecular residual disease research and 5-base genomic analysis.
From Comprehensive Genomic Profiling to Multiomics: Innovations in Precision Oncology
Hear from Illumina experts and customer speakers about developments in comprehensive genomic profiling, whole-genome sequencing, MRD research, methylation, and precision oncology.
Andrew Slatter, PhD, Director, Scientific Research, Illumina, UK
15 minutes
Li Liu, PhD, Director, Product Development, Illumina, USA
20 minutes
Wendy de Leng, PhD, Clinical Molecular Biologist, University Medical Center Utrecht, Netherlands
20 minutes
Helge Lubenow, PhD, CEO, Heidelberg EpignostiX, Germany
20 minutes
The presentations will be followed by discussion and audience Q&A, moderated by Corina Nickoloff, MBA, Senior Director, Europe and Latin America Marketing, Illumina, Switzerland.
Discussion and Q&A: 5–7 minutes per track
Date: Sunday 13th September
Time: 12:30-14:00
Location: Hall A4